Selzman Jonathan, Gajendran Mahesh, El Kurdi Bara, Katabathina Venkata, Wright Randy, Umapathy Chandraprakash, Echavarria Juan
Department of Internal Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX.
Department of Gastroenterology and Hepatology, The University of Texas Health Science Center at San Antonio, San Antonio, TX.
ACG Case Rep J. 2023 Sep 23;10(9):e01140. doi: 10.14309/crj.0000000000001140. eCollection 2023 Sep.
Nontarget embolization is a rare complication that may occur after a patient undergoes transarterial chemoembolization as a localized treatment of hepatocellular carcinoma. This phenomenon can occur because of variations in arterial blood supply to the liver and ultimately can lead to ischemic complications in unintended locations. We describe a case of nontarget embolization during transarterial chemoembolization causing ischemic colitis because of anatomic variation in the origin of the right hepatic artery. This case highlights the importance of recognizing rare side effects associated with this procedure and the need for comprehensive imaging to assess for anatomical variation to avoid poor outcomes.
非靶栓塞是一种罕见的并发症,可能发生在患者接受经动脉化疗栓塞作为肝细胞癌的局部治疗之后。这种现象可能是由于肝脏动脉血液供应的变异引起的,最终可能导致非预期部位的缺血性并发症。我们描述了一例经动脉化疗栓塞过程中发生的非靶栓塞病例,该病例因右肝动脉起源的解剖变异导致缺血性结肠炎。该病例强调了认识与该手术相关的罕见副作用的重要性,以及进行全面成像以评估解剖变异以避免不良后果的必要性。